ABSTRACT NUMBER: ESOC2026A1665 SAFETY OF DUAL-ROUTE ALLOGENEIC UMBILICAL MESENCHYMAL STEM CELL THERAPY IN ACUTE ISCHEMIC STROKE
Sheng-Ta Tsai, Yuh-Cherng Guo, Cheng-Li Lin, Hei-Tung Yip, Wei-Chun Wang, Kang-Hsu Lin, Chen Wei-Laing, Long-Bin Jeng, Woei-Cherng Shyu, Chon-Haw Tsai · 2026
Read ABSTRACT NUMBER: ESOC2026A1665 SAFETY OF DUAL-ROUTE ALLOGENEIC UMBILICAL MESENCHYMAL STEM CELL THERAPY IN ACUTE ISCHEMIC STROKE by Sheng-Ta Tsai, Yuh-Cherng Guo, Cheng-Li Lin, Hei-Tung Yip, Wei-Chun Wang, Kang-Hsu Lin, Chen Wei-Laing, Long-Bin Jeng, Woei-Cherng Shyu, Chon-Haw Tsai (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13146812.txt.
Description
Sheng-Ta Tsai and co-authors ran a small safety trial of stem cells for acute stroke, reported in a 2026 conference abstract. Clot removal saves brain tissue, yet many patients still recover poorly. The cells came from donated umbilical cords. Ten patients with a major artery stroke got the cells by vein within a day and a half of onset, then by catheter into the brain artery on day seven.
No serious treatment-linked harms appeared. Two patients had passing kidney trouble judged unrelated to the cells. The trial's point was safety, not proof of benefit. Clean early results clear the way for larger trials asking whether the cells aid recovery.
Catalog record
| CREATOR | Sheng-Ta Tsai, Yuh-Cherng Guo, Cheng-Li Lin, Hei-Tung Yip, Wei-Chun Wang, Kang-Hsu Lin, Chen Wei-Laing, Long-Bin Jeng, Woei-Cherng Shyu, Chon-Haw Tsai |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |